In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best cheap dividend stocks to buy right now. Value investing has remained a favored approach ...

Investors with a lot of money to spend have taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other oversold blue chip stocks. The uncertainty related to the tariff announcements continues ...

NEW YORK, March 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

New version of Merck's Keytruda faces possible patent battle, WSJ reports Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday. Merck has opened a $1 billion, 225,000-square ...

Merck & Co is to pay $10 million to Hanmi to repurpose an obesity drug discarded by Johnson & Johnson, into a therapy for the fatty liver disease known as NASH. Non-alcoholic steatohepatitis ...